purchase customization

1 Introduction to Research & Analysis Reports
1.1 Oncology Based Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Based Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Based Molecular Diagnostics Overall Market Size
2.1 Global Oncology Based Molecular Diagnostics Market Size: 2021 VS 2028
2.2 Global Oncology Based Molecular Diagnostics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Oncology Based Molecular Diagnostics Sales: 2017-2028
3 Company Landscape
3.1 Top Oncology Based Molecular Diagnostics Players in Global Market
3.2 Top Global Oncology Based Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Oncology Based Molecular Diagnostics Revenue by Companies
3.4 Global Oncology Based Molecular Diagnostics Sales by Companies
3.5 Global Oncology Based Molecular Diagnostics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Oncology Based Molecular Diagnostics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Oncology Based Molecular Diagnostics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Based Molecular Diagnostics Players in Global Market
3.8.1 List of Global Tier 1 Oncology Based Molecular Diagnostics Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology Based Molecular Diagnostics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Based Molecular Diagnostics Market Size Markets, 2021 & 2028
4.1.2 PCR
4.1.3 Multiplex PCR
4.1.4 In Situ Hybridization
4.1.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.2 By Type - Global Oncology Based Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Oncology Based Molecular Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Oncology Based Molecular Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Oncology Based Molecular Diagnostics Revenue Market Share, 2017-2028
4.3 By Type - Global Oncology Based Molecular Diagnostics Sales & Forecasts
4.3.1 By Type - Global Oncology Based Molecular Diagnostics Sales, 2017-2022
4.3.2 By Type - Global Oncology Based Molecular Diagnostics Sales, 2023-2028
4.3.3 By Type - Global Oncology Based Molecular Diagnostics Sales Market Share, 2017-2028
4.4 By Type - Global Oncology Based Molecular Diagnostics Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Oncology Based Molecular Diagnostics Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Prostate Cancer
5.1.4 Colorectal Cancer
5.1.5 Cervical Cancer
5.1.6 Other
5.2 By Application - Global Oncology Based Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Oncology Based Molecular Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Oncology Based Molecular Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Oncology Based Molecular Diagnostics Revenue Market Share, 2017-2028
5.3 By Application - Global Oncology Based Molecular Diagnostics Sales & Forecasts
5.3.1 By Application - Global Oncology Based Molecular Diagnostics Sales, 2017-2022
5.3.2 By Application - Global Oncology Based Molecular Diagnostics Sales, 2023-2028
5.3.3 By Application - Global Oncology Based Molecular Diagnostics Sales Market Share, 2017-2028
5.4 By Application - Global Oncology Based Molecular Diagnostics Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Oncology Based Molecular Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Oncology Based Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Oncology Based Molecular Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Oncology Based Molecular Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Oncology Based Molecular Diagnostics Revenue Market Share, 2017-2028
6.3 By Region - Global Oncology Based Molecular Diagnostics Sales & Forecasts
6.3.1 By Region - Global Oncology Based Molecular Diagnostics Sales, 2017-2022
6.3.2 By Region - Global Oncology Based Molecular Diagnostics Sales, 2023-2028
6.3.3 By Region - Global Oncology Based Molecular Diagnostics Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Oncology Based Molecular Diagnostics Revenue, 2017-2028
6.4.2 By Country - North America Oncology Based Molecular Diagnostics Sales, 2017-2028
6.4.3 US Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.4.4 Canada Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.4.5 Mexico Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Oncology Based Molecular Diagnostics Revenue, 2017-2028
6.5.2 By Country - Europe Oncology Based Molecular Diagnostics Sales, 2017-2028
6.5.3 Germany Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.4 France Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.5 U.K. Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.6 Italy Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.7 Russia Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.8 Nordic Countries Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.5.9 Benelux Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Oncology Based Molecular Diagnostics Revenue, 2017-2028
6.6.2 By Region - Asia Oncology Based Molecular Diagnostics Sales, 2017-2028
6.6.3 China Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.6.4 Japan Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.6.5 South Korea Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.6.6 Southeast Asia Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.6.7 India Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Oncology Based Molecular Diagnostics Revenue, 2017-2028
6.7.2 By Country - South America Oncology Based Molecular Diagnostics Sales, 2017-2028
6.7.3 Brazil Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.7.4 Argentina Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oncology Based Molecular Diagnostics Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Oncology Based Molecular Diagnostics Sales, 2017-2028
6.8.3 Turkey Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.8.4 Israel Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.8.5 Saudi Arabia Oncology Based Molecular Diagnostics Market Size, 2017-2028
6.8.6 UAE Oncology Based Molecular Diagnostics Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Major Product Offerings
7.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Becton Dickinson
7.3.1 Becton Dickinson Corporate Summary
7.3.2 Becton Dickinson Business Overview
7.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Major Product Offerings
7.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.3.5 Becton Dickinson Key News
7.4 Cepheid
7.4.1 Cepheid Corporate Summary
7.4.2 Cepheid Business Overview
7.4.3 Cepheid Oncology Based Molecular Diagnostics Major Product Offerings
7.4.4 Cepheid Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.4.5 Cepheid Key News
7.5 Dako
7.5.1 Dako Corporate Summary
7.5.2 Dako Business Overview
7.5.3 Dako Oncology Based Molecular Diagnostics Major Product Offerings
7.5.4 Dako Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.5.5 Dako Key News
7.6 Danaher Corporation
7.6.1 Danaher Corporation Corporate Summary
7.6.2 Danaher Corporation Business Overview
7.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Major Product Offerings
7.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.6.5 Danaher Corporation Key News
7.7 Gen Probe(Hologic)
7.7.1 Gen Probe(Hologic) Corporate Summary
7.7.2 Gen Probe(Hologic) Business Overview
7.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Major Product Offerings
7.7.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.7.5 Gen Probe(Hologic) Key News
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Corporate Summary
7.8.2 Roche Diagnostics Business Overview
7.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Major Product Offerings
7.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.8.5 Roche Diagnostics Key News
7.9 Siemens Healthcare
7.9.1 Siemens Healthcare Corporate Summary
7.9.2 Siemens Healthcare Business Overview
7.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Major Product Offerings
7.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Sales and Revenue in Global (2017-2022)
7.9.5 Siemens Healthcare Key News
8 Global Oncology Based Molecular Diagnostics Production Capacity, Analysis
8.1 Global Oncology Based Molecular Diagnostics Production Capacity, 2017-2028
8.2 Oncology Based Molecular Diagnostics Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology Based Molecular Diagnostics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology Based Molecular Diagnostics Supply Chain Analysis
10.1 Oncology Based Molecular Diagnostics Industry Value Chain
10.2 Oncology Based Molecular Diagnostics Upstream Market
10.3 Oncology Based Molecular Diagnostics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology Based Molecular Diagnostics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer